ITF Pharma
Manufacturing · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
850 Cassatt Rd Ste 350, Berwyn, Pennsylv...Phone Number
(484) 328-4964Website
www.itfpharma.comRevenue
$17.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ITF Pharma
Italfarmaco SpA is a private multinational pharmaceutical group founded in 1938, based in Milan, Italy, dedicated to researching, developing, and producing high-quality prescription and over-the-counter drugs. The company focuses on innovative solutions for disease prevention, management, and cure, with a particular emphasis on rare diseases. Italfarmaco aims to improve healthcare accessibility and effectiveness through pioneering research and development in key therapeutic areas. Their commitment to science and patient well-being drives their mission to create impactful treatments for patients and society.Explore more
ITF Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ITF Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ITF Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if ITF Pharma has recently received funding, and reach out quickly before it becomes old news!
ITF Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ITF Pharma has new funding data
Product Launch: Get notified when ITF Pharma launches new products
Earning: See what the market has to say on ITF Pharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at ITF Pharma
Click to see if ITF Pharma had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined ITF Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to ITF Pharma
Compare insights from companies similar to ITF Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2008
DW
Daniel WorleyVice President, Business Development & Associate General Counsel
Company Profile Activity
Activity Insights
ITF Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ITF Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ITF Pharma.
ITF Pharma financials insights
Gather financial insights about ITF Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
ITF Pharma Tech Stack
A closer look at the technologies used by ITF Pharma
ITF Pharma News & Media
ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastronomy (PEG) Feeding Tube
ITF Pharma, a U.S.-based specialty pharmaceutical company and subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label for TIGLUTIK® (riluzole) oral suspension to include administration via percutaneous endoscopic gastrostomy (PEG) tubes for the treatment of amyotrophic lateral sclerosis (ALS). This supplemental new drug application (sNDA) apprITF Pharma Announces Availability Of TIGLUTIK™ (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) In The United States
BERWYN, Pa., Oct. 15, 2018 /PRNewswire/ -- ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, announced today the U.S. availability of its first commercial product, TIGLUTIK™ (riluzole)...ITF Pharma Announces FDA Approval Of TIGLUTIK™ (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ -- ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, committed to investing in and commercializing impactful medicines in therapeutic areas with...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ITF Pharma
Sign Up For FreeTo access detailed company insights
Italfarmaco SpA is a private multinational pharmaceutical group founded in 1938, based in Milan, Italy, dedicated to researching, developing, and producing high-quality prescription and over-the-counter drugs. The company focuses on innovative solutions for disease prevention, management, and cure, with a particular emphasis on rare diseases. Italf... Read More
